Stay updated on Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and 'Multiple myeloma' along with the related topic 'MedlinePlus Genetics' were removed from the page topics.
    Difference
    0.2%
    Check dated 2025-11-26T13:59:28.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Added related topics 'Multiple myeloma' and 'MedlinePlus Genetics' to the study page to provide disease context and references. Removed the government funding status notice that previously informed users about operating status and updates.
    Difference
    0.5%
    Check dated 2025-11-19T08:39:56.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Added Multiple Myeloma as a topic and MedlinePlus Genetics as a related topic to the page’s metadata, improving discoverability and access to related resources.
    Difference
    0.2%
    Check dated 2025-11-04T12:05:19.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2025-10-28T05:22:17.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.
    Difference
    4%
    Check dated 2025-10-06T15:53:07.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Update terminology and topic scope: replace 'Plasma cell myeloma' with 'Multiple myeloma' and add MedlinePlus Genetics topics, reflecting a move toward standardized, genetics-linked content (v3.1.0 vs v3.0.2).
    Difference
    0.6%
    Check dated 2025-09-29T09:49:01.000Z thumbnail image

Stay in the know with updates to Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial page.